A U.S. medical professor facing fraud charges for submitting false data in Alzheimer's disease research, impacting a publicly-listed pharmaceutical company and raising integrity concerns about its drug development. The case highlights the potential consequences of research misconduct.
The Justice Department has announced criminal charges against 193 defendants, including medical professionals, for their involvement in health care fraud schemes amounting to billions of dollars.
Supreme Court blocks Purdue Pharma's bankruptcy settlement, protecting the Sackler family from opioid epidemic lawsuits and impacting billions in potential settlements.
The U.S. Food and Drug Administration issued draft guidance for drugmakers and medical device makers to improve diversity in clinical trials, emphasizing the importance of actions to support more equitable access to medical innovations.
Judge rules in favor of AHA, declaring HHS's online tracking restrictions unlawful, impacting hospitals' use of web technologies for health information sharing.
Conexiant
Daily News
Stay up to date with the latest clinical headlines.
Judge rules in favor of AHA, declaring HHS's online tracking restrictions unlawful, impacting hospitals' use of web technologies for health information sharing.
The FDA has expanded the approval of Sarepta Therapeutics' gene therapy, Elevidys, for Duchenne muscular dystrophy in patients aged four and older, addressing both ambulatory and non-ambulatory cases.
The Congressional Budget Office projects a rise in the uninsured rate to 8.9% by 2034, driven by immigration and policy changes affecting young adults, despite a record low of 7.2% in 2023.